KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Change in Intangibles (2016 - 2025)

Historic Change in Intangibles for Biogen (BIIB) over the last 14 years, with Q4 2025 value amounting to $16.3 million.

  • Biogen's Change in Intangibles fell 3962.96% to $16.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $31.6 million, marking a year-over-year decrease of 8466.76%. This contributed to the annual value of $31.6 million for FY2025, which is 8466.76% down from last year.
  • As of Q4 2025, Biogen's Change in Intangibles stood at $16.3 million, which was down 3962.96% from $5.3 million recorded in Q3 2025.
  • Over the past 5 years, Biogen's Change in Intangibles peaked at $95.0 million during Q3 2024, and registered a low of $1.0 million during Q4 2022.
  • Its 5-year average for Change in Intangibles is $21.0 million, with a median of $11.7 million in 2023.
  • In the last 5 years, Biogen's Change in Intangibles skyrocketed by 140000.0% in 2024 and then plummeted by 9442.11% in 2025.
  • Biogen's Change in Intangibles (Quarter) stood at $16.9 million in 2021, then plummeted by 94.08% to $1.0 million in 2022, then surged by 1240.0% to $13.4 million in 2023, then soared by 101.49% to $27.0 million in 2024, then tumbled by 39.63% to $16.3 million in 2025.
  • Its Change in Intangibles stands at $16.3 million for Q4 2025, versus $5.3 million for Q3 2025 and $10.0 million for Q1 2025.